| 
收听数0听众数8最后登录2025-1-7QQUID9301阅读权限10帖子1191精华0在线时间380 小时注册时间2014-5-1
 
 
 科研币2 速递币25 娱乐币1820 文献值0 资源值0 贡献值0 
 | 
5速递币 
| | 题名 | Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study |  | 链接 | http://www.sciencedirect.com/science/article/pii/S147020451470381X | 
 | 
 |